Master Protocols, EUAs for COVID-19 and the ouster of BARDA’s Bright: a BioCentury podcast

In the latest edition of the BioCentury This Week PODCAST, BioCentury Editor in Chief Simone Fishburn interviews Senior Editor Lauren Martz about the difference master protocol trials are making in the race to develop countermeasures against COVID-19, and Washington Editor Steve Usdin about allegations by ousted BARDA Director Rick Bright that cronyism has crippled the U.S. pandemic response.

Martz explains how master protocol trials that produce rapid clinical readouts and share resources are playing an increasingly important role in the race to develop COVID-19 countermeasures. The U.K. government has set the bar for master protocol implementation by prioritizing three trials that span the different stages of the disease (“U.K. Sets the Bar for COVID-19 Master Protocols”)...